Athersys CEO: Trial Results Will Prove Stock Surge Sustainable

Now watching

Next video starts in : 7 Play

Athersys CEO: Trial Results Will Prove Stock Surge Sustainable

Athersys CEO: Trial Results Will Prove Stock Surge Sustainable
Replay video
Up next

Sin City Saints Episode 1: The Fool Monty

Unlock your personal NFL Now stream by signing in to NFL.com

Athersys CEO: Trial Results Will Prove Stock Surge Sustainable

by TheStreet.com Videos 3:05 mins

Athersys CEO: Trial Results Will Prove Stock Surge Sustainable

by TheStreet.com Videos 3:05 mins

Shares of Athersys, which have nearly doubled in the past 3 months, should keep their momentum as a number of data points concerning the company's regenerative medicine treatments roll in, says Gil Van Bokkelen, CEO of Athersys. Van Bokkelen says the company's lead drug MultiStem is entering into a number of late stage clinical trials across a number of illnesses. He also says the company is making huge strides with patents in Japan and has successfully raised enough cash to carry it forward.

Must Watch

Must Watch

  1. 22:03

    Sin City Saints Episode 1: The Fool Monty

  2. 23:15

    Sin City Saints Episode 2: Smoke and Mirrors

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 1:22

    Meet the star point guard of the Sin City Saints

  5. 2:52

    A 900 Calorie Cocktail? What's in Your Drink?

Community

  1. 27:26

    Community Episode 1: Ladders

  2. 27:26

    Community Episode 2: Lawnmower Maintenance and Postnatal Care

  3. 24:40

    Community Episode 3: Basic Crisis Room Decorum

  4. 0:29

    Watch a Sneak Peek of Community Episode 4

  5. 2:01

    Sin City Saints: Official Trailer